NEW YORK (GenomeWeb) – Enzo Biochem announced after the close of the market on Thursday that its third quarter earnings rose 2 percent year over year, thanks largely to an 8 percent increase in revenues from its clinical lab business.

For the three months ended April 30, the company reported revenues of $27.1 million, up from $26.4 million in Q3 2016.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.